GLP-1 drugs like Ozempic are reshaping consumer appetites, with nearly half of users eating less beef. As this trend accelerates, meat producers face a challenge, while plant-based brands are presented with an opportunity.
The growing demand for diabetes-friendly snacks presents a lucrative opportunity for the food industry to merge taste with nutritional balance. With consumers increasingly seeking blood sugar-friendly options, a new movement related to snacking has taken root.
Alt-meat brands like Beyond and Impossible are launching new and reformulated products to earn the trust of health-conscious consumers and national health organizations. These innovations have enabled the meat alternatives to quality for the nutrition initiatives of both the American Heart and American Diabetes Associations.
GLP-1 weight-loss drugs are transforming dieting culture, offering a relatively easy solution to weight loss. While these drugs may disrupt food consumption patterns, their long-term impact hinges on overcoming high dropout rates and premium pricing, one industry insider says.
The approvals signal a potential disruption to traditional animal- and plant-based ingredients that have long dominated consumer packaged goods (CPG).
Recent diet “hacks” to minimize blood sugar spikes are inspiring perfectly healthy consumers to start glucose monitoring.
Like many diets, indulgences, and vices, “everything in moderation” is a good rubric by which to evaluate one’s actions if implementing a food-as-medicine nutritional plan.
Despite their utility in enhancing the flexibility and durability of plastic, plasticizers have infiltrated most facets of food production.
Americans are getting away from healthy habits like meal prepping and perusing produce aisles. Instead, many consumers opt for quicker, more convenient food that often include preservatives and copious amounts of sugar or oils.
The latest Food Institute news podcast discusses which food and beverage brands resonate with Gen Z consumers.
Eating red meat just twice a week may increase the risk of developing type 2 diabetes, according to a new Harvard University study. Meanwhile, data shows that a relatively small percentage of people eat a …
With 17% of children ages 10 to 17 considered obese, consideration is being given to whether diabetes drugs like Ozempic should be made available to kids. Health experts have concerns.
The latest Food Institute news podcast touches on a potential breakthrough in diabetes care and insulin medication.
The soup and shake diet has grabbed headlines recently, but some medical experts fear its drastic requirements send a bad message.
Type 2 diabetes continues to be diagnosed at a staggering rate, even though it’s often preventable—so what, exactly, is going on?
